Total submissions: 9
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genomic Diagnostic Laboratory, |
RCV000239026 | SCV000297308 | uncertain significance | not specified | 2015-07-29 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV001093961 | SCV000370165 | uncertain significance | Fanconi anemia complementation group F | 2018-01-12 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. |
Labcorp Genetics |
RCV000320511 | SCV000547716 | uncertain significance | Fanconi anemia | 2025-02-02 | criteria provided, single submitter | clinical testing | This sequence change replaces glutamine, which is neutral and polar, with histidine, which is basic and polar, at codon 211 of the FANCF protein (p.Gln211His). This variant is present in population databases (rs146975768, gnomAD 0.05%). This missense change has been observed in individual(s) with FANCF-related condition (PMID: 33850299). ClinVar contains an entry for this variant (Variation ID: 252737). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is not expected to disrupt FANCF protein function with a negative predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Institute for Clinical Genetics, |
RCV001358441 | SCV002011028 | uncertain significance | not provided | 2021-11-03 | criteria provided, single submitter | clinical testing | |
Genetic Services Laboratory, |
RCV000239026 | SCV002066360 | uncertain significance | not specified | 2019-04-04 | criteria provided, single submitter | clinical testing | |
Sema4, |
RCV000320511 | SCV002530496 | uncertain significance | Fanconi anemia | 2021-09-29 | criteria provided, single submitter | curation | |
Gene |
RCV001358441 | SCV002562428 | uncertain significance | not provided | 2022-11-11 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge; This variant is associated with the following publications: (PMID: 29641532) |
Fulgent Genetics, |
RCV001093961 | SCV002816750 | likely benign | Fanconi anemia complementation group F | 2024-02-13 | criteria provided, single submitter | clinical testing | |
Department of Pathology and Laboratory Medicine, |
RCV001358441 | SCV001554175 | uncertain significance | not provided | no assertion criteria provided | clinical testing |